Tet2 Mouse shRNA Plasmid (Locus ID 214133)
CAT#: TG513547
Tet2 - Mouse, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 3 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Tet2 Mouse shRNA Plasmid (Locus ID 214133) |
Locus ID | 214133 |
UniProt ID | Q4JK59 |
Synonyms | Ayu17-449; E130014J05Rik; mKIAA1546 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | Tet2 - Mouse, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 214133). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001040400, NM_001346736, NM_001040400.1, NM_001040400.2, BC031159, BC040785, NM_145989 |
Summary | Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Has a preference for 5-hydroxymethylcytosine in CpG motifs. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (3)
The use of this RNAi has been cited in the following citations: |
---|
TET2 Protects against oxLDL-Induced HUVEC Dysfunction by Upregulating the CSE/H2S System
,null,
Frontiers in Pharmacology
,PubMed ID 28798687
[Tet2]
|
Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro
,null,
Scientific Reports
,PubMed ID 28272491
[Tet2]
|
Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE−/− mice
,null,
Oncotarget
,PubMed ID 27821816
[Tet2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...